Clinical Research Directory
Browse clinical research sites, groups, and studies.
The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
Sponsor: Danish Breast Cancer Cooperative Group
Summary
The majority of early breast cancer patients are treated with adjuvant radiation therapy (RT) as part of their multimodal therapy. The aim of the RT is to lower the risk of local, regional and distant failure and improve survival. Modern RT is been provided with photon therapy. Now, more proton therapy facilities are opened, including in Denmark. Proton RT may have the potential to cause lower dose to heart and lung during breast RT. This trial will randomise patients between standard photon RT versus experimental proton RT. The primary endpoint is 10 year risk of heart disease.
Official title: The DBCG Proton Trial. Adjuvant Breast Proton Radiation Therapy for Early Breast Cancer Patients: The Skagen Trial 2, a Clinically Controlled Randomised Phase III Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1502
Start Date
2020-06-01
Completion Date
2037-06-01
Last Updated
2020-10-08
Healthy Volunteers
No
Interventions
Proton versus photon radiation therapy
The intervention is proton radiation therapy versus photon radiation therapy
Locations (8)
Aalborg University Hospital
Aalborg, Denmark
Aarhus University Hospital
Aarhus, Denmark
The Danish Breast Cancer Cooperative Group
Copenhagen, Denmark
Rigshospitalet
Copenhagen, Denmark
Herlev Hospital
Herlev, Denmark
Naestved Hospital
Næstved, Denmark
Odense University Hospital
Odense, Denmark
Vejle Hospital
Vejle, Denmark